Search

everythinglearnresearchcommunity

for

Search:↓

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Non-motor symptoms in myasthenia gravis are common and need early diagnosis for better management.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New genes found linked to balding, may help develop future treatments.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

PRP, especially AA-PRP, can help improve hair growth in androgenetic alopecia.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Non-coding RNAs could help detect and treat radiation damage.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Mutations in certain receptors can cause diseases and offer new treatment options.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Non-immune factors play a significant role in alopecia areata.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.